TGase2 Inhibitors

The class of TGase2 inhibitors encompasses a diverse group of chemical compounds with the potential to modulate the activity of tissue transglutaminase 2 (TGase2), a multifunctional enzyme involved in various cellular processes, including protein cross-linking and post-translational modifications. This array of compounds, including Bithionol, Curcumin, Monodansylcadaverine, R283, Dihydroxyphenylglycine, L682777, Benzyloxycarbonyl-Lys-FMK, Cystamine, Dansylcadaverine, GRL-008, and Glutathione monoethyl ester, exhibits different mechanisms of action and potential impacts on TGase2. Bithionol, known for its uncoupling activity on oxidative phosphorylation, could indirectly modulate TGase2 by disrupting mitochondrial function. The alteration in mitochondrial function may have downstream effects on cellular processes, including TGase2 activity. Curcumin, a natural polyphenol with anti-inflammatory and antioxidant properties, may influence TGase2 activity indirectly by impacting cellular signaling pathways. The modulation of these pathways by Curcumin could lead to changes in TGase2 activity, highlighting its potential as a modulator of cellular processes.

Monodansylcadaverine and Dansylcadaverine, polyamine analogs, might act as substrate analogs for TGase2, potentially inhibiting its enzymatic activity by competing with natural substrates. These compounds offer a direct approach to inhibiting TGase2 by mimicking its natural substrates. R283, though its specific mechanism is currently unclear, shows potential in modulating TGase2 activity. Further research is needed to elucidate the precise molecular interactions and pathways through which R283 influences TGase2. Benzyloxycarbonyl-Lys-FMK, as a potential substrate analog, may directly inhibit TGase2 by competing with natural substrates. This direct inhibition strategy offers a targeted approach to modulating TGase2 activity. Cystamine and Glutathione monoethyl ester may impact TGase2 indirectly by influencing cellular redox status and signaling pathways, leading to alterations in TGase2 activity. These compounds provide an indirect route to modulating TGase2 by affecting cellular conditions that are conducive or inhibitory to its activity.